[Relation between the anti-inflammatory effect and inhibiting activity of monoaminoxidase inhibitors].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000633:toxicity; D006834:Hydrazines / Q000494:pharmacology / Q000633:toxicity; D007490:Iproniazid / Q000494:pharmacology / Q000633:toxicity; D007538:Isoniazid / Q000494:pharmacology / Q000633:toxicity; D007928:Lethal Dose 50; D008930:Mitochondria, Liver / Q000187:drug effects / Q000201:enzymology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology* / Q000633:toxicity; D010293:Pargyline / Q000494:pharmacology / Q000633:toxicity; D051381:Rats; D014191:Tranylcypromine / Q000494:pharmacology / Q000633:toxicity
D000893:Anti-Inflammatory Agents; D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D014191:Tranylcypromine; D010293:Pargyline; D007490:Iproniazid; D007538:Isoniazid
Zavisimost' mezhdu protivovospalitel'nym deĭstviem i ingibiruiushcheĭ aktivnost'iu blokatorov monoaminoksidazy.